Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy

NCT02573766 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT02573766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02573766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy
Lead sponsor
M.D. Anderson Cancer Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 1, 2015
Completion date
October 1, 2026
Enrollment
91 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain